Literature DB >> 7972118

Elevated dopa decarboxylase activity in living brain of patients with psychosis.

J Reith1, C Benkelfat, A Sherwin, Y Yasuhara, H Kuwabara, F Andermann, S Bachneff, P Cumming, M Diksic, S E Dyve, P Etienne, A C Evans, S Lal, M Shevell, G Savard, D F Wong, G Chouinard, A Gjedde.   

Abstract

The hypofrontality theory of the pathogenesis of schizophrenia predicts that cortical lesions cause psychosis. During a search for abnormalities of catecholaminergic neurotransmission in patients with complex partial seizures of the mesial temporal lobe, we discovered an increase of the rate of metabolism of an exogenous dopa tracer (6-[18F]fluoro-L-dopa) in the neostriatum of a subgroup of patients with a history of psychosis. When specifically assayed for this abnormality, patients with schizophrenia revealed the same significant increase of the rate of metabolism in the striatum. The finding is consistent with the theory that a state of psychosis arises when episodic dopamine excess is superimposed on a trait of basic dopamine deficiency in the striatum. The finding is explained by the hypothesis that cortical insufficiency, a proposed pathogenetic mechanism of both disorders, causes an up-regulation of the enzymes responsible for dopa turnover in the neostriatum as well as the receptors mediating dopaminergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972118      PMCID: PMC45289          DOI: 10.1073/pnas.91.24.11651

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Anatomical mapping of functional activation in stereotactic coordinate space.

Authors:  A C Evans; S Marrett; P Neelin; L Collins; K Worsley; W Dai; S Milot; E Meyer; D Bub
Journal:  Neuroimage       Date:  1992-08       Impact factor: 6.556

2.  A classification of hand preference by association analysis.

Authors:  M Annett
Journal:  Br J Psychol       Date:  1970-08

3.  Schizophrenia as dopamine-deficiency disease.

Authors:  G Chouinard; B D Jones
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

4.  Monoamine oxidase inhibitors (MAOI) increase rat brain aromatic amino acid decarboxylase activity.

Authors:  I C Campbell; D L Murphy; M N Walker; W Lovenberg; D S Robinson
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

5.  Positive and negative schizophrenic symptoms and the role of dopamine.

Authors:  A V Mackay
Journal:  Br J Psychiatry       Date:  1980-10       Impact factor: 9.319

6.  Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats.

Authors:  C J Pycock; R W Kerwin; C J Carter
Journal:  Nature       Date:  1980-07-03       Impact factor: 49.962

7.  NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones.

Authors:  A B MacDermott; M L Mayer; G L Westbrook; S J Smith; J L Barker
Journal:  Nature       Date:  1986 May 29-Jun 4       Impact factor: 49.962

8.  Dopamine visualized in the basal ganglia of living man.

Authors:  E S Garnett; G Firnau; C Nahmias
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

9.  Epileptic psychosis--diagnostic comparison with process schizophrenia.

Authors:  M M Perez; M R Trimble
Journal:  Br J Psychiatry       Date:  1980-09       Impact factor: 9.319

10.  Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology.

Authors:  J G Peters
Journal:  Eur Neurol       Date:  1979       Impact factor: 1.710

View more
  83 in total

1.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

Authors:  A Abi-Dargham; J Rodenhiser; D Printz; Y Zea-Ponce; R Gil; L S Kegeles; R Weiss; T B Cooper; J J Mann; R L Van Heertum; J M Gorman; M Laruelle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 2.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

3.  Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations.

Authors:  Oliver D Howes; Paul Shotbolt; Michael Bloomfield; Kirstin Daalman; Arsime Demjaha; Kelly M J Diederen; Kemal Ibrahim; Euitae Kim; Philip McGuire; René S Kahn; Iris E Sommer
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

4.  Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.

Authors:  Paolo Fusar-Poli; Andreas Meyer-Lindenberg
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

Review 5.  [Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts].

Authors:  P Falkai; W Maier
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

6.  Seasonal effects on human striatal presynaptic dopamine synthesis.

Authors:  Daniel P Eisenberg; Philip D Kohn; Erica B Baller; Joel A Bronstein; Joseph C Masdeu; Karen F Berman
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

Review 7.  Is schizophrenia a dopamine supersensitivity psychotic reaction?

Authors:  Mary V Seeman; Philip Seeman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-10-12       Impact factor: 5.067

8.  Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.

Authors:  Dean F Wong; James R Brasić; Harvey S Singer; David J Schretlen; Hiroto Kuwabara; Yun Zhou; Ayon Nandi; Marika A Maris; Mohab Alexander; Weiguo Ye; Olivier Rousset; Anil Kumar; Zsolt Szabo; Albert Gjedde; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2007-11-07       Impact factor: 7.853

9.  Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing.

Authors:  Rajendra A Morey; Seniha Inan; Teresa V Mitchell; Diana O Perkins; Jeffrey A Lieberman; Aysenil Belger
Journal:  Arch Gen Psychiatry       Date:  2005-03

Review 10.  A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications.

Authors:  George E Jaskiw; Anand P Popli
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.